Aytu BioPharma (AYTU) Stock Chart & Stock Price History → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free AYTU Stock Alerts $2.94 -0.02 (-0.68%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Aytu BioPharma Stock Price Performance5 Day Performance-11.45%1 Month Performance+5.38%3 Month Performance-7.26%6 Month Performance+28.38%Year-To-Date Performance+3.52%1 Year Performance+52.33% Receive AYTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. AYTU Stock Chart for Sunday, May, 19, 2024 AYTU Chart by TradingView Aytu BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.96$2.94-0.68%$2.96$2.9021,134 shs$16.38 million05/16/2024$3.06$2.96-3.27%$3.35$2.7540,652 shs$16.49 million05/15/2024$3.32$3.06-7.83%$3.40$3.0645,354 shs$17.04 million05/14/2024$3.31$3.32+0.30%$3.45$3.2422,624 shs$18.49 million05/13/2024$3.27$3.31+1.22%$3.42$3.2359,967 shs$18.44 million05/10/2024$3.18$3.24+1.89%$3.26$3.1715,211 shs$18.04 million Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$3.15$3.18+0.95%$3.20$3.079,482 shs$17.71 million05/08/2024$3.06$3.15+2.94%$3.18$3.076,093 shs$17.55 million05/07/2024$3.06$3.06$3.11$3.055,914 shs$17.04 million05/06/2024$3.01$3.06+1.66%$3.17$3.0443,531 shs$17.04 million05/03/2024$3.01$3.01$3.04$2.9221,150 shs$16.77 million05/02/2024$2.89$3.01+4.04%$3.01$2.957,349 shs$16.77 million05/01/2024$2.81$2.89+2.96%$2.95$2.857,935 shs$16.12 million04/30/2024$2.81$2.81$2.89$2.812,653 shs$15.65 million04/29/2024$2.90$2.81-3.25%$2.93$2.813,834 shs$15.65 million04/26/2024$2.84$2.82-0.70%$2.92$2.826,134 shs$15.71 million04/25/2024$2.80$2.84+1.43%$2.87$2.717,951 shs$15.82 million04/24/2024$2.71$2.80+3.32%$2.80$2.6313,960 shs$15.60 million04/23/2024$2.78$2.71-2.52%$2.85$2.719,066 shs$15.10 million04/22/2024$2.79$2.78-0.36%$2.88$2.756,642 shs$15.49 million04/19/2024$2.79$2.79$2.83$2.746,921 shs$15.54 million04/18/2024$2.87$2.79-2.90%$2.93$2.793,294 shs$15.54 million04/17/2024$2.92$2.87-1.60%$2.94$2.764,308 shs$16.00 million04/16/2024$2.67$2.92+9.36%$2.92$2.687,382 shs$16.26 million04/15/2024$2.89$2.67-7.61%$2.86$2.6555,660 shs$14.87 million04/12/2024$3.12$2.89-7.38%$3.12$2.8426,458 shs$16.10 million04/11/2024$3.26$3.12-4.29%$3.22$3.0826,603 shs$17.37 million04/10/2024$3.36$3.26-2.98%$3.36$3.1513,404 shs$18.15 million04/09/2024$3.30$3.36+1.82%$3.38$3.2713,205 shs$18.72 million04/08/2024$3.22$3.30+2.48%$3.35$3.1040,063 shs$18.38 million04/05/2024$3.20$3.20$3.22$3.0915,837 shs$17.82 million04/04/2024$3.13$3.20+2.24%$3.20$2.9821,840 shs$17.82 million04/03/2024$3.03$3.13+3.30%$3.13$3.0412,003 shs$17.43 million04/02/2024$2.99$3.03+1.34%$3.04$2.9810,254 shs$16.88 million04/01/2024$3.04$2.99-1.64%$3.17$2.9715,656 shs$16.65 million03/29/2024$3.04$3.04$3.12$3.0115,205 shs$16.93 million03/28/2024$3.08$3.04-1.30%$3.12$3.0115,205 shs$16.93 million03/27/2024$3.08$3.08$3.09$2.9113,819 shs$17.16 million03/26/2024$3.07$3.08+0.33%$3.09$3.057,482 shs$17.16 million03/25/2024$3.04$3.07+0.99%$3.17$2.9841,292 shs$17.10 millionHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs03/22/2024$2.98$3.04+2.01%$3.11$2.946,165 shs$16.93 million03/21/2024$2.89$2.98+3.11%$3.07$2.8710,038 shs$16.60 million03/20/2024$2.86$2.89+1.05%$2.97$2.8821,331 shs$16.10 million03/19/2024$2.89$2.86-1.04%$2.97$2.8613,205 shs$15.93 million03/18/2024$2.87$2.89+0.70%$3.11$2.8262,253 shs$16.10 million03/15/2024$2.87$2.87$2.96$2.8411,517 shs$15.99 million03/14/2024$3.05$2.87-5.90%$3.14$2.7626,215 shs$15.99 million03/13/2024$3.15$3.05-3.17%$3.22$3.0111,322 shs$16.99 million03/12/2024$3.15$3.15$3.23$3.1222,750 shs$17.55 million03/11/2024$3.14$3.15+0.32%$3.25$3.0617,642 shs$17.54 million03/08/2024$3.09$3.18+2.91%$3.20$3.0924,242 shs$17.71 million03/07/2024$2.99$3.09+3.34%$3.09$3.0122,813 shs$17.21 million03/06/2024$3.04$2.99-1.64%$3.09$2.9713,171 shs$16.65 million03/05/2024$2.93$3.04+3.75%$3.07$2.9029,011 shs$16.93 million03/04/2024$2.96$2.93-1.01%$3.00$2.8337,856 shs$16.32 million03/01/2024$2.89$2.96+2.42%$2.96$2.8318,120 shs$16.49 million02/29/2024$2.96$2.89-2.36%$3.00$2.8330,740 shs$16.10 million02/28/2024$2.84$2.96+4.23%$2.98$2.8340,736 shs$16.49 million02/27/2024$2.89$2.84-1.73%$2.92$2.834,793 shs$15.82 million02/26/2024$2.93$2.89-1.37%$2.92$2.8110,151 shs$16.09 million02/23/2024$2.97$2.96-0.34%$2.99$2.8225,307 shs$16.49 million02/22/2024$3.00$2.97-1.00%$3.09$2.9115,172 shs$16.54 million02/21/2024$3.28$3.00-8.54%$3.28$2.8132,232 shs$16.71 million02/20/2024$3.17$3.28+3.47%$3.34$3.1356,380 shs$18.27 million02/19/2024$3.17$3.17$3.40$3.1045,000 shs$17.66 million Related Companies: Talphera Stock Price Chart VBI Vaccines Stock Price Chart Traws Pharma Stock Price Chart Minerva Neurosciences Stock Price Chart Vaxxinity Stock Price Chart Vincerx Pharma Stock Price Chart Indaptus Therapeutics Stock Price Chart NeuroSense Therapeutics Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Cocrystal Pharma Stock Price Chart Receive AYTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AYTU) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.